Voltage-gated sodium channels
6 drugs2
approved indications
6
Approved Drugs
6
Companies
4
Indications
0
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (6 companies)
✓ All 6 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (4 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
UCB INC 1 drug
AUCTA 1 drug
OMNIVIUM PHARMS 1 drug
By Therapeutic Area
Other 6 drugs
Drugs by Company PRO
UCB INC 1 drug
AUCTA 1 drug
OMNIVIUM PHARMS 1 drug
Dr. Reddy's 1 drug
SUMITOMO PHARMA AM 1 drug
SK LIFE 1 drug
By Therapeutic Area
Other 6 drugs
VIMPAT, MOTPOLY XR, NUMBRINO, ESLICARBAZEPINE ACETATE +2 more
Indications Treated
Local AnesthesiaPartial-Onset SeizuresGeneralized Tonic-Clonic SeizuresTonic-Clonic Seizures
All Drugs Targeting Voltage-gated sodium channels
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| VIMPAT | UCB INC | 2008 | 2 | |
| MOTPOLY XR | AUCTA | 2023 | 2 | |
| NUMBRINO | OMNIVIUM PHARMS | 2020 | 1 | |
| ESLICARBAZEPINE ACETATE | Dr. Reddy's | 2021 | 1 | |
| APTIOM | SUMITOMO PHARMA AM | 2013 | 1 | |
| XCOPRI | SK LIFE | 2019 | 1 |